ARTICLE | Clinical News
Anascorp regulatory update
August 8, 2011 7:00 AM UTC
FDA approved Anascorp from Rare Disease to treat scorpion stings by Centruroides scorpions. The product is expected to launch in early September, with a wholesale acquisition cost of $3,500 per vial. ...